ESR1 and breast cancer: The main aim of this study was to determine whether D metabolites produced by sulfotransferase and by microbiota enzymes maintain their anticancer effects, consisting in affecting ERα activities that are important for E2-induced resistance of breast cancer cells to chemotherapeutic injury.